1. Neoadjuvant chemotherapy versus chemoradiotherapy for resectable pancreatic head adenocarcinoma: a propensity score matched analysis. (April 2017) Authors: Mokdad, A.; Minter, R.; Zhu, H.; Augustine, M.; Porembka, M.; Wang, S.; Yopp, A.; Mansour, J.; Choti, M.; Polanco, P. Journal: HPB Issue: Volume 19(2017)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2. Issue 2 (20th January 2017) Authors: Popovic, B.; Breed, J.; Rees, D.G.; Gardener, M.J.; Vinall, L.M.K.; Kemp, B.; Spooner, J.; Keen, J.; Minter, R.; Uddin, F.; Colice, G.; Wilkinson, T.; Vaughan, T.; May, R.D. Journal: Journal of molecular biology Issue: Volume 429:Issue 2(2017) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The influence of HPB fellowship training on the practice of pancreatoduodenectomy. (April 2016) Authors: McMillan, M.; Bassi, C.; Greig, P.; Hansen, P.; Jeyarajah, D.; Kent, T.; Malleo, G.; Minter, R.; Sprys, M.; Vollmer, C. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗